Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-07-11 @ 10:24 AM
Study NCT ID:
NCT02974504
Status:
COMPLETED
Last Update Posted:
2018-07-23
First Post:
2016-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
Sponsor:
Dong-A ST Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type2 Diabetes | View |
Keywords: